Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavia Barbi

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Chirurgia Italiana|August 12, 2008
[Molecular medicine in thyroid surgery]Sonia Moretti, Flavia Barbi, Maria Tavano, et al.
Proteomics. Clinical Applications|December 8, 2010
Identification of differentially expressed proteins in papillary thyroid carcinomas with V600E mutation of BRAFEfisio Puxeddu, Federica Susta, Pier Luigi Orvietani, et al.
Biochimica Et Biophysica Acta|September 9, 2009
Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motifSonia Moretti, Valentina De Falco, Anna Tamburrino, et al.
Clinical Endocrinology|January 13, 2006
Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns))Claudio Carta, Sonia Moretti, Lucia Passeri, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 13, 2008
Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer propertiesAndrea Prodosmo, Simona Giglio, Sonia Moretti, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Chirurgia Italiana|August 12, 2008
[Molecular medicine in thyroid surgery]Sonia Moretti, Flavia Barbi, Maria Tavano, et al.
Proteomics. Clinical Applications|December 8, 2010
Identification of differentially expressed proteins in papillary thyroid carcinomas with V600E mutation of BRAFEfisio Puxeddu, Federica Susta, Pier Luigi Orvietani, et al.
Biochimica Et Biophysica Acta|September 9, 2009
Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motifSonia Moretti, Valentina De Falco, Anna Tamburrino, et al.
Clinical Endocrinology|January 13, 2006
Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns))Claudio Carta, Sonia Moretti, Lucia Passeri, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 13, 2008
Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer propertiesAndrea Prodosmo, Simona Giglio, Sonia Moretti, et al.
Pageof 1